Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt this powerful approach to breast cancer and analyse 515 cells from 11 patients. Inferred copy number variations from the single-cell RNA-seq data separate carcinoma cells from non-cancer cells. At a single-cell resolution, carcinoma cells display common signatures within the tumour as well as intratumoral heterogeneity regarding breast cancer subtype and crucial cancer-related pathways. Most of the non-cancer cells are immune cells, with three distinct clusters of T lymphocytes, B lymphocytes and macrophages. T lymphocytes and macrophages both display immunosuppressive characteristics: T cells with a regulatory or an exhausted phenotype and macrophages with an M2 phenotype. These results illustrate that the breast cancer transcriptome has a wide range of intratumoral heterogeneity, which is shaped by the tumour cells and immune cells in the surrounding microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Limited T-cell recruitment and function in the TME correlates with poor prognosis in BC (21,22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“4.0b (default parameters) 55 , and relative gene expression was quantified as transcript per million (TPM) using RSEM v1.”
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To assess gene expression signatures and pathway activation, a non-parametric and unsupervised software algorithm called GSVA software in the R package 58 with the RNA-seq mode was used.”
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“To further delineate the identity of carcinoma and non-carcinoma cells, we analysed the expression of tumour-associated stromal or immune gene sets proposed in the tumour purity estimation, ESTIMATE 26 .”
Cited by
Items 301–400 of 999
Welter, L. M., Xu, L., McKinley, D., Dago, A. E., Prabakar, R. K., Restrepo-Vassalli, S., Xu, K., Rodríguez-Lee, M., Kolatkar, A. R., Nevarez, R., et al. (2020) · Molecular Case Studies · doi:10.1101/mcs.a005819 · Cited by 39
“…multiplex proteomics as well as characterizing the circulating tumor microenvironment could all provide an even deeper characterization of a patient ’ s tumor, its evolution, and response to therapy (Goon et al. 2009; Chung et al. 2017; Mastoraki et al. 2018; Jackson et al. 2020; Rao et al. 2020).”
Lim, H. S., & Qiu, P. (2023) · Journal of Computational Biology · doi:10.1089/cmb.2022.0366 · Cited by 45
“…have provided novel opportunities for new insights and discoveries by unveiling cellular heterogeneity at single-cell resolution (Ajami et al., 2018; Chung et al., 2017; Villani et al., Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, Georgia, USA.”
Wang, T., Zhao, H. F., Xu, Y., Wang, Y., Shang, X., Peng, J., & Xiao, B. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad384 · Cited by 40
Geeleher, P., Nath, A., Wang, F., Zhang, Z., Barbeira, A., Fessler, J. L., Grossman, R. L., Seoighe, C., & Huang, R. S. (2018) · Genome biology · doi:10.1186/s13059-018-1507-0 · Cited by 40
“However, the pervasive genomic aberrations and dysregulation of key master regulators that occur in cancer cells [18] could”
BackgroundInfluentialOn the Mathematics of RNA Velocity I: Theoretical Analysis
Li, T., Shi, J., Wu, Y., & Zhou, P. (2021) · CSIAM Transactions on Applied Mathematics · doi:10.4208/csiam-am.so-2020-0001 · Cited by 44
Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective
Ortiz, M. M. O., & Andrechek, E. R. (2023) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-023-09540-2 · Cited by 38
“In breast cancer, while bulk RNAseq was found to closely resemble single-cell profiling, particularly in the Luminal and HER2-enriched subtypes, the single-cell approach helped to define other characteristics important to the understanding of cancer biology [14].”
BackgroundLiu, Y., Altreuter, J., Bodapati, S., Cristea, S., Wong, C. J., Wu, C. J., & Michor, F. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100444 · Cited by 48
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer
Li, Y., Chang, R. B., Stone, M. L., Delman, D., Markowitz, K., Xue, Y., Coho, H., Herrera, V. M., Li, J. H., Zhang, L., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101397 · Cited by 45
Self-citationRecent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer
Khella, C. A., Mehta, G. A., Mehta, R. N., & Gatza, M. L. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020149 · Cited by 36
Liu, S., Zhou, B., Wu, L. L., Sun, Y., Chen, J., & Liu, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-84693-w · Cited by 33
Differences in Tumor Immune Microenvironment in Metastatic Sites of Breast Cancer
Lee, H., Na, K. J., & Choi, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.649004 · Cited by 42
Self-citationStaquicini, F. I., Hajitou, A., Driessen, W. H. P., Proneth, B., Cardó‐Vila, M., Staquicini, D. I., Markosian, C., Hoh, M., Cortéz, M., Hooda-Nehra, A., et al. (2021) · eLife · doi:10.7554/elife.65145 · Cited by 37
Zhu, X., Fang, H., Gladysz, K., Barbour, J. A., & Wong, J. W. H. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.08.003 · Cited by 35
Fang, K., Ohihoin, A. G., Liu, T., Choppavarapu, L., Nosirov, B., Wang, Q., Yu, X., Kamaraju, S., Leone, G. W., & Jin, V. X. (2024) · Genome Medicine · doi:10.1186/s13073-024-01407-3 · Cited by 38
Kim, N., Chung, W., Eum, H. H., Lee, H., & Park, W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217196 · Cited by 35
Self-citationCombined heterogeneity in cell size and deformability promotes cancer invasiveness
Asadullah, Kumar, S., Saxena, N., Sarkar, M., Barai, A., & Sen, S. (2021) · Journal of Cell Science · doi:10.1242/jcs.250225 · Cited by 44
IDO Inhibition Facilitates Antitumor Immunity of Vγ9Vδ2 T Cells in Triple-Negative Breast Cancer
Li, P., Wu, R., Li, K., Yuan, W., Zeng, C., Zhang, Y., Wang, X., Zhu, X., Zhou, J., Li, P., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.679517 · Cited by 40
Jeong, J., Shin, J. H., Li, W., Hong, J. Y., Lim, J., Hwang, J. Y., Chung, J., Yan, Q., Liu, Y., Choi, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110160 · Cited by 37
“…cancer patients identified a HER2-positive cell population (cluster 2) where co-expression of MAL2 with HER2 occurred in 95.9% of HER2-positive cells as compared with co-expression of Flotillin with HER2, which occurred in 49.3% of HER2-positive cells (Figures 1E and S1A) (Chung et al., 2017).”
InfluentialGu, S., Qian, L. M., Zhang, Y., Chen, K., Li, Y., Wang, J., & Wang, P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188632 · Cited by 41
de Oliveira, K. A., Sengupta, S., Yadav, A. K., & Clarke, R. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1083048 · Cited by 39
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Beigi, Y. Z., Lanjanian, H., Fayazi, R., Salimi, M., Hoseyni, B. H. M., Noroozizadeh, M. H., & Masoudi‐Nejad, A. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00182-2 · Cited by 37
Yates, J., Kraft, A., & Boeva, V. (2025) · Genome biology · doi:10.1186/s13059-025-03559-w · Cited by 37
“To further demonstrate that dissociation-induced stress does not strongly drive elevated pctMT in the cancer cells passing other QC measures, we compared mitochondrial gene expression between paired bulk and scRNA-seq datasets from two breast cancer studies [25, 35].”
Jonasson, E., Ghannoum, S., Persson, E., Karlsson, J. W., Kroneis, T., Larsson, E., Landberg, G., & Ståhlberg, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00500 · Cited by 35
Single-Cell RNA Sequencing-Based Computational Analysis to Describe Disease Heterogeneity
Zeng, T., & Dai, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00629 · Cited by 36
“…have suggested distinct patterns in the tumor microenvironment, e.g., the breast cancer transcriptome has shown a wide range of intratumoral heterogeneity that is reshaped by both immune and tumor cells in a closely communicated microenvironment at a single-cell resolution (Chung et al., 2017).”
BackgroundWu, S., Zhang, H., Fouladdel, S., Li, H., Keller, E. T., Wicha, M. S., Omenn, G. S., Azizi, E., & Guan, Y. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.005 · Cited by 35
Mammary gland development from a single cell ‘omics view
Twigger, A., & Khaled, W. T. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.03.013 · Cited by 32
Mao, X., Zhou, D., Lin, K., Zhang, B., Gao, J. T., Ling, F., Zhu, L., Yu, S., Chen, P., Zhang, C., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03278-2 · Cited by 35
“first revealed the comprehensive tumor and immune profiles in primary BC at the single-cell RNA level, although their cell number was very limited [14].”
Advances in single-cell omics: Transformative applications in basic and clinical research
Inayatullah, M., Dwivedi, A. K., & Tiwari, V. K. (2025) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2025.102548 · Cited by 48
Xiang, S. D., Wilson, K., Goubier, A., Heyerick, A., & Plebanski, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02968 · Cited by 31
“An additional major emerging trend for cancer immunotherapy is the ability to use high-throughput analysis “omics” techniques, such as transcriptomics, to define tumor subtypes and cancer cell heterogeneity (10, 11).”
BackgroundDong, Y., Wang, Z., & Shi, Q. (2020) · PROTEOMICS · doi:10.1002/pmic.201900224 · Cited by 33
Yu, Z., Lu, W., Su, C., Lv, Y., Ye, Y., Guo, B., Liu, D., Yan, H., Mi, H., Li, T., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.659251 · Cited by 39
Epigenetic loss of heterogeneity from low to high grade localized prostate tumours
Eksi, S. E., Chitsazan, A., Sayar, Z., THOMAS, G. V., Fields, A. J., Kopp, R. P., Spellman, P. T., & Adey, A. (2021) · Nature Communications · doi:10.1038/s41467-021-27615-8 · Cited by 35
Furukawa, N., Stearns, V., Santa-Maria, C. A., & Popel, A. S. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2170779 · Cited by 37
“A single-cell study demonstrated that T cells in TNBC expressed higher level of genes related to cytotoxicity and exhaustion compared to T cells in other breast cancer subtypes [29].”
Saurty-Seerunghen, M. S., Bellenger, L., El-Habr, E. A., Delaunay, V., Garnier, D., Chneiweiss, H., Antoniewski, C., Morvan-Dubois, G., & Junier, M. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0819-y · Cited by 33
Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches
Lin, T. (2022) · Cancers · doi:10.3390/cancers14092059 · Cited by 35
Huo, X., Ma, S., Wang, C., Song, L., Yao, B.-H., Zhu, S., Li, P., Wang, L., Wu, Z., & Wang, K. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1429 · Cited by 31
“34 Compared with macroC2, macroC1 had a higher M2 score, which revealed that macroC1 was more similar to M2 macrophages (Figure S13).”
ResultSchnell, A., Schmidl, C., Herr, W., & Siska, P. J. (2018) · Biomedicines · doi:10.3390/biomedicines6010025 · Cited by 36
A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer
Nederlof, I., Horlings, H. M., Curtis, C. N., & Kok, M. (2021) · Cancers · doi:10.3390/cancers13020316 · Cited by 34
“Single cell RNA sequencing Single cell transcriptome sequencing to assess gene expression patterns for each cell individually RNA No Single cell [6,21,23,28,29]”
MethodSingle-cell RNA-seq variant analysis for exploration of genetic heterogeneity in cancer
Fasterius, E., Uhlén, M., & Szigyarto, C. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-45934-1 · Cited by 32
Winkler, J., Tan, W., Diadhiou, C. M. M., McGinnis, C. S., Abbasi, A. J., Hasnain, S., Durney, S., Atamaniuc, E., Superville, D. A., Awni, L., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci164227 · Cited by 45
Self-citationHlady, R. A., & Robertson, K. D. (2018) · Seminars in Liver Disease · doi:10.1055/s-0037-1621712 · Cited by 31
A Simple Guideline to Assess the Characteristics of RNA-Seq Data
Son, K. H., Yu, S., Shin, W., Han, K., & Kang, K. (2018) · BioMed Research International · doi:10.1155/2018/2906292 · Cited by 33
Xing, J., & Tian, X. (2019) · Physical Biology · doi:10.1088/1478-3975/ab0032 · Cited by 33
“[123] Chung W et al 2017 Single-cell RNA-seq enables”
BackgroundResearch advances and new challenges in overcoming triple-negative breast cancer
Zong, Y., & Pegram, M. D. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.04 · Cited by 45
Zhang, S., Gong, C., Ruiz-Martínez, Á., Wang, H., Davis-Marcisak, E. F., Deshpande, A. M., Popel, A. S., & Fertig, E. J. (2021) · ImmunoInformatics · doi:10.1016/j.immuno.2021.100002 · Cited by 32
“into a spQSP model to enable patient-specific simulations [45].”
BackgroundMethodInfluentialDeep Learning in Single-cell Analysis
Molho, D., Ding, J., Tang, W., Li, Z., Wen, H., Wang, Y., Venegas, J., Jin, W., Liu, R., Su, R., et al. (2024) · ACM Transactions on Intelligent Systems and Technology · doi:10.1145/3641284 · Cited by 49
“In oncology, single-cell sequencing has allowed for the identification of rare cells in tumors and how they contribute to tumor progression [124].”
BackgroundWang, R., Zheng, X., Wang, J., Wan, S., Song, F., Wong, M. H., Leung, K. S., & Cheng, L. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac002 · Cited by 34
Fontana, F., Esser, A. K., Egbulefu, C., Karmakar, P. S., Su, X., Allen, J. S., Xu, Y., Davis, J. L., Gabay, A. J., Xiang, J., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293700 · Cited by 34
Végh, P., & Haniffa, M. A. (2018) · Briefings in Functional Genomics · doi:10.1093/bfgp/ely003 · Cited by 29
“Studies that combined single-cell profiling with tumour spatial heterogeneity analysis have identified multiple mechanisms of cancer-associated immunosuppression, including tumour-infiltrating T cell dysfunction [87] and immunosuppressive tumoural T cells and macrophages [88].”
BackgroundViability Assessment Following Anticancer Treatment Requires Single-Cell Visualization
Mirzayans, R., Andrais, B., & Murray, D. L. (2018) · Cancers · doi:10.3390/cancers10080255 · Cited by 36
Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales
Fan, L., Li, Y., Chen, J., Zheng, Y., & Xu, X. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.050 · Cited by 30
Ning, Z.-K., Hu, C.-G., Huang, C., Liu, J., Zhou, T.-C., & Zong, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.626912 · Cited by 28
Single-Cell Long Non-Coding RNA Landscape of T Cells in Human Cancer Immunity
Luo, H., Bu, D., Shao, L., Yang, L., Sun, L. D., Wang, C., Wang, J., Yang, W. C., Yang, X., Dong, J., et al. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.02.006 · Cited by 33
Hsieh, Y.-P., Wu, Y., Cheng, S. M., Lin, F.-K., Hwang, D., Jiang, S. S., Chen, K.-C., Chen, M., Chiang, W., Liu, K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094833 · Cited by 30
“In breast cancer research, it has been applied to cluster cell populations in breast tumors with different molecular subtypes to identify distinct populations possibly related to poor prognosis and drug resistance [38,39].”
BackgroundXue, L., Wang, C., Qian, Y., Zhu, W., Liu, L., Yang, X., Zhang, S., & Luo, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111196 · Cited by 31
Cui, J., Christin, J. R., Reisz, J. A., Cendali, F. I., Sanawar, R., de Miranda, M. C., D’Alessandro, A., & Guo, W. (2023) · Science Advances · doi:10.1126/sciadv.adh1891 · Cited by 34
“S2C) ( 27 – 29 ).”
MethodUnravelling immune microenvironment features underlying tumor progression in the single-cell era
Du, Q., An, Q., Zhang, J., Liu, C., & Hu, Q. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03335-z · Cited by 30
Xie, J., Liu, W., Deng, X., Wang, H., Ou, X., An, X., Situ, M., Yang, A., Peng, C., He, R., et al. (2025) · Advanced Science · doi:10.1002/advs.202500722 · Cited by 36
Merlotti, A., Malizia, Á. L., Michea, P., Bonté, P., Goudot, C., Carregal, M. S., Núñez, N. G., Sedlik, C., Ceballos, A., Soumelis, V., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1629257 · Cited by 31
“In Figure 3(b,c), tumor and different lineages of non-tumor cells where identified using gene expression signatures previously described.(24) As shown on Figure 3(d,e), clusterin is predominantly expressed by tumor and stromal cells, but not by tumor infiltrating immune cells.”
BackgroundMethodYu, X., Zhang, L., Chaudhry, A., Rapaport, A. S., & Ouyang, W. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.6mr0320-234r · Cited by 27
Systemic Sclerosis Perturbs the Architecture of the Immunome
Paleja, B. S., Low, A. H. L., Kumar, P., Saidin, S., Lajam, A. B. M., Hazirah, S. N., Chua, C. J. H., Yun, L. L., & Albani, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01602 · Cited by 30
Leveraging Single-Cell Sequencing for Chimeric Antigen Receptor T Cell Therapies
Castellanos-Rueda, R., Roberto, R. B. D., Schlatter, F. S., & Reddy, S. T. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2021.03.005 · Cited by 24
Immunotherapy of cancer in single-cell RNA sequencing era: A precision medicine perspective
Erfanian, N., Derakhshani, A., Nasseri, S., Fereidouni, M., Baradaran, B., Tabrizi, N. J., Brunetti, O., Bernardini, R., Silvestris, N., & Safarpour, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112558 · Cited by 29
Development of a novel BRCAness score that predicts response to PARP inhibitors
Oshi, M., Gandhi, S., Wu, R., Asaoka, M., Yan, L., Yamada, A., Yamamoto, S., Narui, K., Chishima, T., Ishikawa, T., et al. (2022) · Biomarker Research · doi:10.1186/s40364-022-00427-8 · Cited by 28
Peng, S., Hebert, L. L., Eschbacher, J. M., & Kim, S. (2020) · Cancers · doi:10.3390/cancers12123639 · Cited by 32
Self-citationSingle-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review
Thomas, D. D., Lacinski, R. A., & Lindsey, B. A. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100475 · Cited by 29
Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype
Gao, Z., Fang, H., Sun, S., Liu, S.-Q., Zhou, F., Liu, Z., Li, B., Wang, P., Sun, S., Meng, X., et al. (2024) · Theranostics · doi:10.7150/thno.96163 · Cited by 33
Zhang, Z., Chen, B., Zhu, Y., Zhang, T., Zhang, X., Yuan, Y., & Xu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.664375 · Cited by 28
“Whereas breast cancer cells are decidedly heterogeneous in nature, transcriptomic analyses powered by next-generation sequencing techniques have greatly facilitated the elucidation of the origins from which malignant breast cancer cells are derived and the molecular mechanisms that fuel the malignant transformation (C…”
BackgroundRen, X., Zhou, C., Lu, Y., Ma, F., Fan, Y., & Wang, C. (2021) · Bioengineered · doi:10.1080/21655979.2021.1962484 · Cited by 26
“Currently, scRNA-seq has been widely used in various types of disease research, including in breast cancer and pancreatic cancer [11,12].”
MethodLi, C., Liu, D., Yang, S., & Hua, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.966291 · Cited by 31
Targeting intratumor heterogeneity suppresses colorectal cancer chemoresistance and metastasis
Chao, S., Zhang, F., Yan, H., Wang, L., Zhang, L., Wang, Z., Xue, R., Wang, L., Wu, Z., Jiang, B., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256416 · Cited by 27
“…of heterogeneous tumors, while most studies focus on examining the heterogeneity at specific stages of the tumors, neglecting the dynamic changes in heterogeneous subtypes during cancer progression (Patel et al , 2014; Chung et al , 2017; Li et al , 2017; Savage et al , 2017; Ma et al , 2020).”
ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data
Romagnoli, D., Boccalini, G., Bonechi, M., Biagioni, C., Fassan, P., Bertorelli, R., Sanctis, V. D., Leo, A. D., Migliaccio, I., Malorni, L., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-5249-x · Cited by 38
“…mammal development and cancer [1, 2]. scRNA-seq techniques are contributing to refine our knowledge of cell types and states [3, 4] and have been successfully used to characterize intratumoral heterogeneity in different tumor types, including glioblastoma [5], melanoma [6] and breast cancer [7].”
BackgroundSCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells
Zagorac, S., de Giorgio, A., Dabrowska, A. F., Kalisz, M., Casas-Vila, N., Cathcart, P. J., Yiu, A., Ottaviani, S., Degani, N., Lombardo, Y., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2612 · Cited by 27
“Subcellular fractionation followed by RT-qPCR indicated that SCIRT mainly localizes in the chromatinassociated compartment of spheres derived from TNBC MDA-MB231 (Fig.”
BackgroundInfluentialSystematic, Protein Activity-based Characterization of Single Cell StatePreprint
Vlahos, L. J., Obradović, A., Worley, J., Tan, X., Howe, A., Laise, P., Wang, A., Drake, C. G., & Califano, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.20.445002 · Cited by 28
Recent Advances on Penalized Regression Models for Biological Data
Wang, P., Chen, S., & Yang, S. (2022) · Mathematics · doi:10.3390/math10193695 · Cited by 31
Estrogen regulates divergent transcriptional and epigenetic cell states in breast cancer
Ors, A., Chitsazan, A., Doe, A. R., Mulqueen, R. M., Ak, Ç., Wen, Y., Haverlack, S., Handu, M., Naldiga, S., Saldivar, J. C., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac908 · Cited by 28
“We further explored intra-patient heterogeneity of transcriptional cell states using a separate dataset (9) consisting of an ER + luminal B type primary tumor (BC03) and matched lymph-node metastasis (BC03LN).”
MethodHuang, M., Xu, S., Li, Y., Li, S., Zhan, X., Qin, C., Su, J., Zhao, Z., He, Y., Qin, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202205525 · Cited by 30
The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology
Lin, V. T. G., & Yang, E. S.-H. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz114 · Cited by 27
“actively investigated and may succeed at predicting responses to immunotherapy where IHC and genomic NGS have failed (57).”
BackgroundJiang, K., Dong, M., Li, C., & Sheng, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.557477 · Cited by 31
Immune Crosstalk Between Lymph Nodes and Breast Carcinomas, With a Focus on B Cells
Alberts, E., Wall, I., Calado, D. P., & Grigoriadis, A. E. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.673051 · Cited by 26
“A variety of TIL-Bs at multiple stages of differentiation, including naïve, GC-like, memory-like, and plasma cells (Chung et al., 2017; Garaud et al., 2019) have been reported within and around the tumor microenvironment (TME) of breast tumors, with a high percentage of TIL-B exhibiting a memory-like phenotype (Buisse…”
BackgroundApplication and prospects of single cell sequencing in tumors
Huang, R. H., Wang, L. X., He, J., & Gao, W. (2021) · Biomarker Research · doi:10.1186/s40364-021-00336-2 · Cited by 26
“SCS can infer populations of B cells that cannot be detected by other analytical methods [53, 54].”
BackgroundMarkerCount: A stable, count-based cell type identifier for single-cell RNA-seq experiments
Kim, H., Lee, J., Kang, K., & Yoon, S. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.06.010 · Cited by 26
“Single-cell RNA-seq technology [1–3] has enabled the transcriptomic analysis of heterogeneous tissue microenvironments [4], such as the tumor microenvironment, wherein various cell types co-exist.”
BackgroundSelf-citationWang, L., Liu, K., Liu, K., Wang, L., Yin, X., Lin, S., Xu, H., Lin, S., Feng, K., Zhou, X., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.11.019 · Cited by 29
Parikh, A. S., Wizel, A., Davis, D., Lefranc-Torres, A., Rodarte-Rascon, A. I., Miller, L. E., Emerick, K. S., Varvares, M. A., Deschler, D. G., Faquin, W. C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111743 · Cited by 26
Abadi, S. A. R., Laghaee, S., & Koohi, S. (2023) · BMC Genomics · doi:10.1186/s12864-023-09344-y · Cited by 27
“We evaluate SECA on a diverse set of challenging single-cell datasets (Klein [23] (GSE65525), Zeisel [24] (GSE60361), Romanov [25] (GSE74672), Chung [26] (GSE75688), Pbmc [27] (https:// suppo rt. 10xge nomics. com/ single- cell- gene-expre ssion/ datas ets/2.”
MethodHormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity
Moisand, A., Madéry, M., Boyer, T., Domblides, C., Blaye, C., & Larmonier, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015048 · Cited by 28
Ushering in Integrated T Cell Repertoire Profiling in Cancer
Jiang, N. J., Schonnesen, A. A., & Ma, K.-Y. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.11.005 · Cited by 27
Attention-based deep clustering method for scRNA-seq cell type identification
Li, S., Guo, H., Zhang, S., Li, Y., & Li, M. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011641 · Cited by 34
Yang, X., Quan, Q., Pan, Y., Zhou, Q., Wu, Y., Zhuang, J., Xu, J., Pan, M., & Han, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620196 · Cited by 25
“characterized the heterogeneous tumor cells and the surrounding immune and stromal cells, and they found that the majority of non-cancer cells were mainly macrophages, T and B lymphocytes, in which both macrophages (M2 phenotype) and lymphocytes (regulatory/exhausted phenotype) were immunosuppressive phenotypes (18).”
BackgroundRanjan, M., Lee, O., Cottone, G., Mehrabad, E. M., Spike, B. T., Zeng, Z., Yadav, S., Chatterton, R. T., Kim, J. J., Clare, S. E., et al. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01455-2 · Cited by 24
Zhang, T., Wang, Y., Dong, Y., Liu, L., Han, Y., Wang, H., Wei, Q., Xia, P., Ma, W., & Li, L. (2022) · Disease Markers · doi:10.1155/2022/1909196 · Cited by 23
“In addition, the immune score and stromal score combined with their genomic fingerprint can be used to identify tumor microenvironment stromal cells and characterize cancer immunologic landscape [22].”
BackgroundYan, Y., Su, L., Huang, S., He, Q., Lu, J., Luo, H., Xu, K., Yang, G., Huang, S., & Chi, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1444426 · Cited by 27
Dang, P., Fisher, S. A., Stefanik, D. J., Kim, J., & Raper, J. A. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007164 · Cited by 30
Meyer, L., Jackson, H. W., Eling, N., Zhao, S., Usui, G., Dakhli, H., Schraml, P., Dettwiler, S., Elfgen, C., Varga, Z., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.06.019 · Cited by 31
Single Amino Acid Variant Discovery in Small Numbers of Cells
Tan, Z., Yi, X., Carruthers, N. J., Stemmer, P. M., & Lubman, D. M. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00694 · Cited by 21
Engineering Multidimensional Evolutionary Forces to Combat Cancer
McCoach, C. E., & Bivona, T. G. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1196 · Cited by 25
Single-Cell Sequencing and Its Applications in Liver Cancer
Tian, B., & Li, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.857037 · Cited by 26
Wang, Y., Lian, B., Zhang, H., Zhong, Y., He, J. Y., Wu, F., Reinert, K., Shang, X., Yang, H., & Hu, J. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad005 · Cited by 25
Anstine, L. J., & Keri, R. A. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.24 · Cited by 23
“This notion is supported by the transcriptional heterogeneity observed across breast cancer patient tumors within the same subtype([86]).”
Clinical Perspectives of Single-Cell RNA Sequencing
Kim, N., Eum, H. H., & Lee, H. (2021) · Biomolecules · doi:10.3390/biom11081161 · Cited by 26
Self-citation
Metadata
- Authors
- Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., Kan, Z., Han, W., & Park, W.-Y.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Pfizer (United States) (US)
- Corresponding author
- Han, Wonshik
- Park, Woong-Yang
- ORCID
- Venue
- Nature Communications
- Published
- 2017-05-05
- Volume
- 8
- Issue
- 1
- Pages
- 15081-15081
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5424158
- OpenAlex
- W2610509384
- Cited by
- 992
- References
- 62
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 116 · 2023: 117 · 2022: 148 · 2021: 191 · 2020: 106 · 2019: 93 · 2018: 63 · 2017: 11
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2015R1A2A2A01008264, 2016R1A5A1011974)
- Samsung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, intratumoral heterogeneity, tumor immune microenvironment, tumor stroma, T cells, B cells, macrophages, regulatory T cells, T cell exhaustion, M2 macrophages, tumor subtypes, tumor transcriptome, copy number variation
- MeSH terms
- Exome Sequencing, B-Lymphocytes, Breast Neoplasms, Female, Humans, Lymph Nodes, Macrophages, Receptors, Estrogen, Receptors, Progesterone, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Sequence Analysis, RNA, Carcinoma, Ductal, Breast, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Gene Expression Profiling, DNA Copy Number Variations, Single-Cell Analysis, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.